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Abstract
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ephrins, they fulfill multiple
biological functions. Aberrant expression of Ephs/ephrins leading to increased Eph receptor to ephrin ligand ratios is a
critical factor in tumorigenesis, indicating that tight regulation of Eph and ephrin expression is essential for normal cell
behavior. The 3’-untranslated regions (3’UTRs) of transcripts play an important yet widely underappreciated role in the
control of protein expression. Based on the assumption that paralogues of large gene families might exhibit a conserved
organization of regulatory elements in their 3’UTRs we applied a novel bioinformatics/molecular biology approach to the
3’UTR sequences of Eph/ephrin transcripts. We identified clusters of motifs consisting of cytoplasmic polyadenylation
elements (CPEs), AU-rich elements (AREs) and HuR binding sites. These clusters bind multiple RNA-stabilizing and
destabilizing factors, including HuR. Surprisingly, despite its widely accepted role as an mRNA-stabilizing protein, we further
show that binding of HuR to these clusters actually destabilizes Eph/ephrin transcripts in tumor cell lines. Consequently,
knockdown of HuR greatly modulates expression of multiple Ephs/ephrins at both the mRNA and protein levels. Together
our studies suggest that overexpression of HuR as found in many progressive tumors could be causative for disarranged
Eph receptor to ephrin ligand ratios leading to a higher degree of tissue invasiveness.
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Introduction
The 3’untranslated regions (3’UTRs) of mRNAs play crucial
roles in posttranscriptional regulation of gene expression, for
example by modulating mRNA localization [1,2,3], stability [4],
and translation [5,6]. Apart from having binding sites for the
recently discovered microRNAs, 3’UTRs can harbor motifs that
interact with specific RNA-binding proteins. These motifs are
normally short-sequence elements whose activity can be influenced
by their secondary structure [7]. Therefore, their identification by
computer algorithms is difficult and usually produces numerous
false positives.
To identify 3’UTR motifs we used a novel approach that is
based on two assumptions: first, not only coding regions but also
elements within the 3’UTRs that are essential to gene function
might be conserved between the paralogues of large gene families;
second, mRNAs encoding proteins that functionally interact or
fulfill redundant functions might exhibit a conserved organization
of regulatory elements in their 3’UTRs. To investigate this, we
chose the families of ephrin ligands and Eph receptors. The family
of Eph receptors is the largest subfamily of receptor tyrosine
kinases. Eph receptors are divided into two subclasses based on
their ligand specificities. In general, Eph class A (EphA) receptors
bind to glycosylphosphatidylinositol-anchored ephrin A ligands
(ephrinA) (with the exception of EphA4), whereas Eph class B
(EphB) receptors bind to transmembrane domain-containing
ephrin B ligands (ephrinB) [8]. However, more recent data suggest
that interactions can also occur across classes [9]. Upon binding to
their cognate ephrin ligands, Eph receptors autophosphorylate
and activate downstream signaling cascades (forward signaling).
Although they do not possess catalytic activity themselves, both
classes of ephrin ligands can activate signal transduction pathways
after interaction with Eph receptors (reverse signaling) [10].
At the cellular level, signaling through Eph receptors and
ephrins leads to either increased adhesion (attraction) or
decreased adhesion (repulsion) of the interacting cells. These
responses are important in mediating a wide range of biological
activities, including angiogenesis, cell segregation, cell attach-
ment, cell morphogenesis, and cell motility [11]. Several of these
processes are out of control during tumorigenesis, highlighting a
potential critical role for Eph/ephrin signaling in the develop-
ment of many human cancers. In line with that pathophysiology,
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several Ephs and ephrins, including EphA1, EphA2, EphA3,
EphA4, EphB2, EphB3, and ephrin-A1, are overexpressed in a
variety of tumors, and exhibit mostly tumor-promoting properties
[11,12].
Expression patterns of Ephs and ephrins are complex, and their
correct expression is essential for the proper function of many of
the processes mentioned above. Therefore, a fine-tuned regulation
of Eph/ephrin expression both at the transcriptional and
posttranscriptional levels would seem to be indispensable. At the
transcriptional level, Eph receptors and ephrin ligands have been
implicated as downstream targets of many different transcription
factors, including homeodomain proteins [13] and the p53 protein
family [14,15,16,17]. Much less is known about posttranscriptional
regulation. However, there is evidence of involvement of the
3’UTR: upregulation of the EphA2 receptor in axons crossing the
midline is mediated by a highly conserved sequence in the
transcript’s 3’UTR that contains a cytoplasmic polyadenylation
element (CPE) [18].
Here we have systematically collected the 3’UTR sequences of
mouse Eph receptors and ephrin ligands and screened them for cis-
acting sequence motifs. We have identified three different types of
motifs in several of the Eph/ephrin 3’UTRs: CPEs, AU-rich
elements (AREs), and HuR binding sites. Whereas some of these
motifs were found to be distributed apparently randomly in the
respective 3’UTRs, others were found to be arrayed in clusters
which are highly conserved between different vertebrate species.
Furthermore, we identified several RNA-binding proteins, includ-
ing HuR, that interact with these clusters, and we show that
EfnA2, EphA2, and EphA4 are direct posttranscriptional targets of
HuR in cancer cell lines. Surprisingly, we found that HuR does
not act as a stabilizing factor upon expression of these Eph/
ephrins, but that it destabilizes the respective messages.
Results
The 3’untranslated regions of transcripts of mouse Eph
receptors and ephrin ligands
To obtain a complete collection of full-length 3’UTR sequences
of mRNAs of Eph receptors and ephrin ligands, we first extracted
all available mouse Eph/ephrin sequences from the GenBank
database of the NCBI. Only polyadenylated transcripts were
considered to be full length, and only such truncating variants that
contain both (i) a consensus hexamer sequence near the cleavage
site and (ii) a poly(A) tail were included in the analysis. Incomplete
transcripts were extended to the poly(A) tail by aligning 3’complete
EST data using the software program CAP3 (for accession
numbers see Table S1). C-terminal truncated isoforms were not
included in the study.
Whereas coding regions and exon/intron boundaries [19] are
highly conserved between the different members of the Eph
receptor and ephrin ligand gene families, the 3’UTRs of
transcripts show a high diversity of length and sequence: those
of the ephrin ligands vary from 552 bp (EfnA4) to 3171 bp (EfnB2)
and those of the Eph receptors from 198 bp (EphB6) to 3310 bp
(EphA4) (Fig. 1, Table S1). Moreover, we could not detect any
significant conservation at the sequence level, either between the
3’UTRs of the Eph receptor transcripts or those of ephrin ligands
(data not shown).
Orthologous conservation between human and mouse varied
from 60% to 80%, which is comparable to the genome-wide mean
value of 69% [20].
Alternative polyadenylation sites were found in the 3’UTRs of
EfnA4, EfnB2, EphA3, and EphA7 (Fig. 1).
The 3’untranslated regions of transcripts of the Eph
receptors and ephrin ligands contain highly conserved
cis-acting sequence motifs
As outlined above, the sequences of Eph/ephrin 3’UTRs are
very poorly conserved between paralogues. However, posttran-
scriptional regulation often relies on short cis-acting sequence
motifs, and genes encoding proteins that functionally interact and/
or genes belonging to the same gene family might be expected to
contain conserved 3’UTR motifs. To detect such elements we
scanned the 3’UTRs of the mouse Eph/ephrin transcripts for
known cis-acting sequence motifs (see http://genereg.molgen.mpg.
de/cgi-bin/regEchse/regEchse.pl : motifs that have been included
in the search are listed under ‘‘select known motif; HuR binding
sites were identified using Transterm http://uther.otago.ac.nz/
Transterm.html). Remarkably, this led to the identification of
three prominent motifs—CPEs, AREs and HuR binding sites—in
several of the Eph/ephrin 3’UTRs (Fig. 1). CPEs are translational
control units that must reside in close proximity to the poly(A) site
to be functional [21]. Therefore, in Figure 1, only those CPEs
which fulfill this criterion [0–250 bp distance from poly(A)
hexamer] are depicted. HuR interacts with multiple AUUUA
repeats [22] and U-rich stretches with high affinity. More recently
attempts have been undertaken to more specifically define an HuR
binding site [23,24]. In a series of binding experiments Meisner et
al. deduced that the HuR binding site is the 9-mer NNUUN-
NUUU. Remarkably this motif was found to be present in all
validated HuR targets, and a single point mutation within the
motif is sufficient to completely destroy HuR binding. In this study
the search for HuR binding sites was based on this motif. Both
AREs and HuR binding sites were found in all parts of the
3’UTRs. Some of the motifs were found as isolated, non-
overlapping elements. In other cases, CPEs were found to overlap
with AREs or HuR binding sites, or AREs with HuR binding sites.
Of note, all three types of motifs, some in multiple copies, were
found together in clusters (Fig. 1, Table S2). These clusters show
two distinct localization patterns: located anywhere in the 3’UTR
with no obvious preference for a special region (e.g. EphA3, see
Fig. 1) or specifically arrayed in the 3’terminal region of the
3’UTR in close proximity to the polyadenylation site (e.g. EphA2,
see Fig. 1).
In orthologous 3’UTRs, cis-acting sequence elements with
important regulatory functions are expected to be conserved
through evolution [24]. For 18 of the 21 mouse Eph/ephrin
3’UTRs investigated in this study, sequences from human
orthologues were available, and 44%, 74%, and 72% of CPEs,
AREs, and HuR binding sites, respectively, were found to be
conserved between the two species (Fig. 1 and 2). Most obvious,
almost all of the motifs arrayed in clusters are conserved. Besides
mammals, orthologous sequences of the 3’UTRs of EfnB2 and
EphA2 from the lower vertebrate Xenopus laevis are available.
Again, especially those motifs that are arrayed in clusters and
located near the poly(A) site were found to be conserved in this
species (Fig. 1 and 2).
Identification of proteins that bind to sequence motifs in
the Eph/ephrin 3’UTRs
On the basis of the following criteria, the 3’terminal parts of the
EfnA1, EphA2, and EphA4 3’UTRs were selected for further
characterization. First, each contains clustered sequence motifs
consisting of CPEs and HuR binding sites. EphA2 and EphA4, in
addition, contain AREs in these clusters. Therefore, the 3’terminal
parts of these 3’UTRs seemed to be good candidates for
identification of proteins interacting with the motif clusters.
3’UTR Motifs of Ephs/ephrins
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Second, all three motif clusters show a high degree of orthologous
conservation in human (Fig. 1). In addition, the EphA2 cluster is
highly conserved in Xenopus laevis (for EfnA1 and EphA4, no
sequence information was available for this species). Third, the
3’terminal region of the EphA2 3’UTR has already been shown to
fulfill important regulatory functions [18].
To test for binding of interacting proteins to these motif clusters,
radioactively labeled transcripts encompassing the 3’terminal
regions of the EfnA1, EphA2, and EphA4 3’UTRs (Fig. 3a) were
incubated with lysate from mouse brain and UV-crosslinked.
Mouse brain was used in this experiment because several known
ARE- and CPE-interacting proteins are highly expressed in this
organ. Complexes were resolved by electrophoresis through SDS
acrylamide gels, and the dried gels were exposed to X-ray film.
Interestingly, this method not only identified several proteins that
had bound to the motif clusters of all three 3’terminal regions, but
also revealed an overlapping banding pattern (Fig. 3b): proteins of
30–45, 50, and 75 kD bound to all three sequences, although the
affinity to the 3’terminal regions of the EphA2 and EphA4
3’UTRs seemed much higher than to that of the EfnA1 3’UTR.
Proteins of ,60 and 70 kD were exclusively detectable in the
EphA2 and EphA4 lanes (Fig. 3b). Identities of the interacting
proteins were determined in an RNA–protein pulldown assay with
subsequent analysis of the eluted fraction by mass spectrometry.
Biotin-labeled in-vitro-transcribed transcripts corresponding to the
3’terminal region of the EphA2 3’UTR were incubated with lysate
from mouse brain and pulled down with streptavidin magnetic
beads. Transcripts in antisense orientation to the chosen region
were used in a negative control experiment. Complexes were
resolved by SDS-PAGE, stained with colloidal Coomassie, and
bands specifically enriched in the sample obtained with the sense
transcripts were analyzed by electrospray ionization (ESI) mass
spectrometry. Interestingly, in addition to several proteins that are
known to be involved in transcription and mRNA splicing—
myelin expression factor 2 (MyEF-2); heterogeneous nuclear
ribonucleoprotein M (hnRNP M); far upstream binding protein
Figure 1. The 3’untranslated regions of Eph receptors and ephrin ligands. Scheme of the 3’UTRs of Eph/ephrins. Putative cis-acting
sequence motifs are highlighted in different colors, conservation between human/mouse, human/mouse/Xenopus is shown by asterisks/open circles.
doi:10.1371/journal.pone.0002780.g001
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1 (FUSE-binding protein 1, FBP); splicing factor, proline- and
glutamine-rich (PSF)—we identified AUF1 and KSRP, two ARE-
binding proteins (ARE-BPs) that are known regulators of mRNA
stability (Fig. 3c, Table 1). To confirm the interaction we repeated
the RNA–protein pulldown assay. This time, however, RNA–
protein complexes were transferred to PVDF membranes and
interacting proteins were detected with specific antibodies. As
expected, KSRP bound to the RNA probe corresponding to the
EphA2 3’UTR terminal region but not to the antisense negative
control (Fig. 3d). Interestingly, concerning AUF1, we could only
detect binding of the p45 and p42 isoforms but not the p40 and
p37 isoforms. Besides ARE and CPE-motifs, the 3’terminal part of
the EphA2 3’UTR harbors a HuR binding site of the consensus
NNUUNNUUU. However, HuR was not identified as an
interacting protein in the mass spectrometry analysis. To test
directly for the binding of HuR we incubated the Western blot
membrane with an antibody directed against endogenous HuR
protein. As expected, HuR was found to specifically interact with
the 3’terminal region of the EphA2 3’UTR.
Based on size similarities of 30–45 kD, the UV-crosslinking
assay suggested binding of the same proteins to the 3’terminal
parts of the EfnA1, EphA2, and EphA4 3’UTRs (Fig. 3b). This
might indicate that expression of several of the Eph receptors and
ephrins is regulated by a shared mechanism. To prove that
identical proteins bind to the motif clusters identified in several
Eph/ephrin 3’UTRs, we performed additional RNA–protein
pulldown assays with in-vitro-transcribed and biotinylated 3’
terminal parts of all the Eph/ephrin 3’UTRs that contain AREs,
CPEs and/or HuR binding sites (Table 2). In addition, we used
the 3’ terminal part of an Eph 3’UTR that does not contain such a
motif (EphA1; the only motif identified in the 3’UTR of this
transcript is an HuR binding site located outside the 3’ terminal
Figure 2. Conservation of 3’terminal parts of Eph/ephrin 3’UTRs containing clustered motifs. Multialignments of representative
examples of clustered motifs as found in the 3’terminal parts of the EfnA1, EfnA4, EphA2 and EphA4 3’UTRs. Positions of CPEs, AREs, HuR binding sites
as well as the consensus hexamer of the polyadenylation signal are indicated below the alignments.
doi:10.1371/journal.pone.0002780.g002
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part). Again, the complexes were transferred to PVDF mem-
branes, and these were incubated with antibodies detecting the
32 kD HuR protein and the four AUF1 isoforms, p37, p40, p42,
and p45, respectively. To our surprise we found that both HuR
and AUF1 p42/p45 bound to some but not all of the transcripts
(Fig. 3e), and the binding patterns of both proteins were only
partially overlapping: both HuR and AUF1 interacted with the 3’
terminal regions of the EfnA2, EfnB2, EphA2, EphA4, and EphA6
3’UTRs, but only AUF1 bound to the 3’ terminal regions of
EfnA1, EphA3, and EphB1 3’UTRs (Fig. 3e). No binding of either
AUF1 or HuR was seen with the 3’ terminal region of EphA1,
which does not contain a motif.
A closer look at the composition of the different 3’UTR
terminal parts revealed that AUF1 had bound to all ARE-
containing transcripts except EphA7, but also to four transcripts
that did not contain an ARE (EfnA1, EfnB2, EphA6, EphB1). For
binding of HuR, presence of the consensus HuR binding site was
essential but not sufficient: we could not detect binding of HuR to
Figure 3. Identification of proteins interacting with clustered motifs harboured in Eph/ephrin 3’UTRs. (A) Scheme of 3’UTRs of EfnA1,
EphA2 and EphA4 as depicted in Fig. 1. Probes used for UV-crosslink and RNA-protein pulldown assays are indicated (B) UV-crosslink with protein
lysate from mouse brain and radioactively labelled probes corresponding to clustered motifs present in the 3’terminal parts of EfnA1, EphA2 and
EphA4 3’UTRs. (C) 10% SDS-gel stained with colloidal Coomassie showing the proteins eluted from streptavidin beads coupled to a biotinylated
probe corresponding to the 3’terminal part of the EphA2 3’UTR (left lane) or to the respective antisense sequence (right lane). Differential bands were
excised and analyzed by mass spectrometry. Protein identities are given. (D) Western blot analyses of RNA-protein pulldowns with protein lysate from
mouse brain and biotinylated probes corresponding to the 3’terminal part of the EphA2 3’UTR (left lane) or to the respective antisense sequence
(right lane). KSRP, AUF1, HuR and hnRNP A0 are detected using specific antibodies. (E) Westernblot analyses of RNA-protein pulldowns with protein
lysate from mouse brain and biotinylated probes corresponding to the 3’terminal parts of Eph/ephrin 3’UTRs or to the EphA2 antisense sequence.
HuR and AUF1 are detected using specific antibodies.
doi:10.1371/journal.pone.0002780.g003
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any of the transcripts lacking this site; however, of the eight
transcripts containing this site, HuR bound to EfnA2, EfnB2,
EphA2, EphA4, and EphA6 but not to EfnA1, EfnB3, and EphB1.
Because HuR binds to single-stranded RNA, it was proposed
that the HuR binding site might have to assume a particular
conformation to undergo high-affinity HuR binding [24].
Therefore, we used the Mfold program to predict secondary
structures in the 3’UTR probes that we had used in the RNA–
protein pulldown assay. In agreement with the results of Meisner
et al. (2004), we found that HuR had interacted only with those
transcripts in which the HuR binding sites were predicted to be
located in single-stranded loops (Fig. 4a). The HuR binding sites of
the remaining transcripts were all (at least partially) located in
double-stranded regions (Fig. 4b) and therefore possibly inacces-
sible to HuR.
The secondary structure of a relatively short partial transcript
may differ greatly from the structure of the whole 3’UTR and
therefore might not reflect the conformation in vivo. To gain insight
into the accessibility of the HuR binding sites harbored in the
Eph/ephrin 3’UTRs we used the Mfold algorithm to predict the
secondary structures of the entire 3’UTRs. Interestingly, apart
from EfnB3 and EphA1, all murine Eph/ephrin 3’UTRs contain
at least one HuR binding site predicted to be part of a single-
stranded region in or outside of the described motif clusters,
suggesting a particularly important role of HuR in the regulation
of Eph/ephrin expression (Fig. S1).
HuR regulates expression of Eph/ephrins in cancer cell
lines
Abnormal expression of Eph/ephrins has been reported in
various cancers, and is associated with poor prognosis and
advanced stages of malignancy [11,25]. While much effort has
been put into the elucidation of transcriptional regulation of Eph/
Table 1. List of proteins that were found to be interacting with the 3’terminal part of the EphA2 3’UTR and their most important
functions.
Protein Accession number Function References
Heterogenous nuclear
ribonucleoprotein D0
(HNRPD, AUF1)
Q60668 RNA/DNA binding, ARE-binding, enhancement of
mRNA decay, telomere elongation, transcription
[48,49,50,51,52]
Myelin expression factor 2
(MyEF-2)
Q8C854 Transcriptional repressor, suppresses transcription
of mouse myelin basic protein gene
[53,54]
Heterogenous nuclear
ribonucleoprotein M (hnRNP M)
Q9D0E1 RNA binding, splicing, carcinoembryonic antigen
receptor
[55,56,57,58]
Far upstream element-binding
protein 1 (FUSE-binding
protein 1, FBP)
Q91WJ8 Transcription factor, regulates MYC expression [59,60]
Far upstream element-binding
protein 2 (KSRP)
Q99PF5 RNA/DNA binding, ARE-binding, alternative splicing,
degradation of ARE-containing mRNAs, activation
of gene expression
[61,62,63,64]
Splicing factor, praline- and
glutamine-rich (PSF)
Q8VIJ6 RNA/DNA binding, splicing, homologous DNA pairing,
transcriptional regulation
[65,66,67]
doi:10.1371/journal.pone.0002780.t001
Table 2. Motifs in biotinylated probes used for RNA-protein pulldown assay and binding patterns of AUF1 (p42/p45) and HuR.
CPE ARE
Bound by AUF1
Fig. 3d
HuR binding site
(total)
HuR binding site (single
strand conformation)
Bound by HuR
Fig. 3d
EfnA1 1 2 + 2 2 2
EfnA2 1 2 ++ 4 2 ++
EfnA4 1 2 2 2 2 2
EfnB2 2 2 ++ 3 1 ++
EfnB3 1 2 2 1 2 2
EphA1 2 2 2 2 2 2
EphA2 2 1 ++ 3 1 +
EphA3 1 1 ++ 2 2 2
EphA4 2 1 ++ 3 1 ++
EphA5 1 2 2 2 2 2
EphA6 1 2 + 1 1 +
EphA7 1 1 2 2 2 2
EphB1 2 2 + 1 2 2
doi:10.1371/journal.pone.0002780.t002
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ephrins in cancer cell lines and cancerous tissues, posttranscrip-
tional regulation has been neglected. Seventy-two percent of the
HuR binding sites of mouse Eph/ephrin 3’UTRs are conserved in
human (see above). To test if our findings in mouse cells also apply
to human cells we immunoprecipitated HuR from the cervical
carcinoma cell line HeLa and the astrocytoma/glioblastoma cell
line U373MG (Fig. 5a) using an anti-HuR antibody, and
performed RT-PCR on the immunoprecipitate with primers
Figure 4. Secondary structures of Eph/ephrin 3’terminal parts. Shown are the secondary structures of the probes used in UV-crosslinking and
RNA-protein pulldown experiments that correspond to the 3’terminal parts of Eph/ephrin 3’UTRs as predicted by Mfold. (A) Probes with HuR binding
sites located in single stranded regions (asterisks) that showed high affinity binding of HuR. (B) Probes where HuR binding sites were predicted to be
harboured in double stranded regions.
doi:10.1371/journal.pone.0002780.g004
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specific for EfnA2, EphA2, and EphA4, which are three mRNAs
known to be highly expressed in various cancer types [11]. As
negative control we performed the same procedure with
nonspecific immunoglobulins instead of anti-HuR antibody
(Fig. 5a and b), and as negative control for RT-PCR we
performed the cDNA-synthesis step without reverse transcriptase
(data not shown). Compared to the negative IgG control, there
was clear enrichment of EfnA2, EphA2, and EphA4 messages in
the immunoprecipitates of both cell lines (Fig. 5b) indicating that
HuR had bound to the Eph/ephrin mRNAs in vivo. Of note, non-
target GAPDH message could also be amplified, albeit less
efficiently and to the same extent in both IP groups; this finding
has been described before [23], and verified the use of equal
amounts of input material.
In a further series of experiments we tested whether HuR
posttranscriptionally regulates Eph/ephrin expression. We
knocked down HuR in HeLa and U373MG cells using two
different HuR-specific siRNA oligonucleotides (Fig. 6a and data
not shown) and detected EfnA2, EphA2, and EphA4 mRNAs by
Real-Time RT-PCR 72 h after transfection. HuR has been
reported as an mRNA stabilizing protein, suggesting that its
knock-down would lead to a reduction of Eph/ephrin mRNA
expression. However, whereas the amount of EphA2 mRNA did
decrease after knock-down of HuR, to our surprise the EfnA2 and
EphA4 mRNA levels increased significantly (Fig. 6a). To test
whether the changes observed at the RNA level reflect the
situation at the protein level we loaded equal amounts of protein
lysates from HeLa and U373 cells after HuR knock-down and
performed Western blot analysis with antibodies detecting EphA2
and EphA4 (Fig. 6b). In confirmation of the Real-Time PCR
experiments we found that expression of EphA2 protein was
drastically reduced by 10-fold in HeLa and 5-fold in U373 cells
after knock-down of HuR, whereas expression of EphA4 was
increased by 1.2-fold and 2-fold, respectively (Fig. 6b). Control
siRNA oligonucleotides did not have a significant effect on EphA2
or EphA4 protein expression when compared to a mock-
transfected control. Of note, the commercially available EphA4
antibody used in this experiment detects three different bands in
HeLa cells (Fig. 6b), all of which were upregulated after HuR
knock-down. Two of these bands may correspond to two different
EphA4 isoforms with a size difference of 37 amino acids that are
listed in the Genome Browser. The third band may represent a
HeLa-specific isoform that has not yet been detected in any of the
conventional databases.
To distinguish between indirect transcriptional effects and direct
mRNA stabilization caused by the knock-down of HuR, we
blocked transcription with actinomycin D 48 h after transfection
of HuR siRNA oligos or control oligos, and measured the mRNA
half-lives of EfnA2, EphA2, and EphA4 by Real-Time RT-PCR.
Surprisingly, we found that knock-down of HuR increased the
half-lives of all Eph/ephrin mRNAs tested. This suggests that
HuR destabilizes these mRNAs (Fig. 7a), and that the decrease in
EphA2 message detected after knock-down of HuR may be caused
by secondary inhibition of EphA2 transcription.
To further confirm that the observed effects are mediated by cis-
acting sequences harbored in the 3’terminal parts of the EfnA2,
EphA2, and EphA4 3’UTRs, pGL3P reporter plasmids carrying
these sequences (including the HuR binding sites) downstream of
the firefly luciferase cDNA were transfected into HeLa cells. For
normalization, the pRL vector containing the Renilla luciferase
cDNA was co-transfected. pGL3P constructs containing the
EfnA2, EphA2 or EphA4 3’terminal sequences produced
significantly less firefly luciferase activity than the pGL3P vector
without 3’UTR inserts, confirming a destabilizing function for the
3’terminal parts of these 3’UTRs (Fig. 7b). After knock-down of
HuR with a specific RNAi oligo this destabilizing effect could be
partially rescued, which further suggests a destabilizing function
for the HuR protein (Fig. 7c). Knock-down of HuR with an RNAi
oligo targeting a different region of the HuR mRNA showed
comparable results (data not shown). Off-target effects were
excluded by transfecting a pGL3P vector without HuR binding
sites.
Discussion
In this study we used a bioinformatics/molecular biology
approach to screen the 3’UTRs of transcripts of Eph receptors and
ephrin ligands for putative cis-acting sequence motifs and to
characterize their biological function.
We show that several of the Eph/ephrin 3’UTRs, although
exhibiting substantial divergence between paralogs in terms of
length and sequence, contain evolutionarily conserved motif
clusters composed of overlapping CPEs, AREs, and HuR binding
sites. We identified HuR and several other proteins involved in
mRNA stability control as interaction partners of these clusters.
Switching from mice to human cancer cell lines, we also obtained
evidence that expression of Eph/ephrins is posttranscriptionally
regulated through interaction of the conserved sequence clusters
and HuR, suggesting a link between misregulation of Eph/ephrin
expression in cancer and overexpression of HuR.
The 3’untranslated regions of transcripts of mouse Eph
receptors and ephrin ligands
A hallmark of members of the Eph/ephrin families is their
expansion of numbers during the course of evolution, due to
Figure 5. In vivo binding of HuR to Eph/ephrin mRNAs. (A)
Immunoprecipitation of endogenous HuR. HeLa or U373 cell lysates
were immunoprecipitated with anti-HuR antibody or with unspecific
IgGs. Immunoprecipitates were loaded on 10% SDS-Pages and analysed
by westernblot with anti-HuR antibody; HC, heavy chain; LC, light chain
(B) RT-PCR after RNA-extraction from the HuR and IgG immunoprecip-
itates with primers specific for EfnA2, EphA2, EphA4 and GAPDH.
doi:10.1371/journal.pone.0002780.g005
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Figure 6. HuR regulates expression of Eph/ephrins. HuR was knocked down with a specific HuR RNAi oligonucleotide in HeLa and U373 cells
(A) mRNA expression of EfnA2, EphA2 and EphA4 72 hours after transfection of a specific HuR RNAi oligo was compared to transfection of a non-
silencing control oligo as measured by Real Time RT-PCR. Ratios between expression levels after HuR knockdown and tranfection of non-silencing
control oligonucleotodides are shown. Values were normalized to GAPDH. (B) Westernblot analyses of protein expression of EphA2, EphA4 (three
isoforms, see arrows), HuR and GAPDH 72 hours after knockdown of HuR (upper panel, lane 3) with specific antibodies in comparison to a mock-
control (lane 1) as well as a non-silencing siRNA control (lane 2). Quantification of bands (Against GAPDH) was performed using the Image Quant
software 5.2 (lower panel). Fold increase or decrease of expression are depicted.
doi:10.1371/journal.pone.0002780.g006
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Figure 7. HuR is a direct regulator of Eph/ephrin mRNA stability. (A) 48 hours after transfection of a specific HuR RNAi oligonucleotide or a
control oligonucleotide the half-lives of EfnA2, EphA2 and EphA4 mRNAs were assessed by using 5 mg/ml Actinomycin D; mRNA half-lives were
measured by Real Time RT-PCR, mRNA expression was normalized to GAPDH. (B) 3’terminal parts of EfnA2, EphA2 and EphA4 3’UTRs were cloned in
pGL3 promoter vector and transfected into HeLa cells. 30 hours after transfection cells were harvested and firefly luciferase activity was measured.
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multiple duplication events [19]. The respective coding regions
and exon/intron boundaries are highly conserved among
orthologues and paralogues, which is reflected by the redundant
functions that Eph/ephrins can fulfill and by the ability of Eph
receptors to interact with multiple ephrins. Moreover, the
3’UTRs of Eph/ephrin orthologues are highly conserved
between human and mouse (up to 80%), which indicates strong
selection pressure and perhaps conservation of distinct expres-
sion profiles. In contrast, the 3’UTRs of Eph/ephrin paralogues
show a high degree of structural divergence, which may have
enabled Ephs/ephrins to acquire diverse expression profiles
(cellular or subcellular), as has been suggested for other
conserved paralogues [26]. Despite their poor overall conser-
vation, the 3’UTRs of 7 of 8 ephrin ligands and 11 of 13 Eph
receptors contain CPEs, AREs, and/or HuR binding sites. The
grouping of several of these motifs into evolutionarily conserved
clusters further emphasizes their functional importance. How-
ever, because neither the position nor composition nor
distribution of these motifs is conserved between paralogous
Eph/ephrins, the clusters may have arisen independently in
evolution. Such convergent evolution has been described for
regulatory elements of other genes coding for proteins that
functionally interact [27,28,29,30]. This is in line with our
observation that conserved motif clusters are present in
functionally interacting Eph/ephrins. For example, transcripts
of the EphA2 receptor and its ligand, ephrin-A1, both contain
conserved clustered motifs, as do the EphA4 receptor and its
ligands, ephrin-A1 and ephrin-B2. Several clustered motifs are
located close to poly(A) sites, which may reflect a function for
these clusters in polyadenylation, as discussed below.
We identified the ARE-binding proteins AUF1 (p42/p45),
KSRP, hnRNP A0, and HuR as interaction partners of the
3’terminal ARE/CPE/HuR clusters. However, we were not able
to show binding of the CPE-interacting factor, cytoplasmic
polyadenylation element binding protein (CPEB), even though
the RNA–protein pulldown assays were done with lysate from
mouse brain, a tissue in which CPEB is strongly expressed and
functional [31,32,33]. Whereas we cannot exclude the possibility
that we could not detect binding of CPEB to Eph/ephrin CPEs for
technical reasons, it might also be that either CPEB is not an
interactor of these CPEs or it was outcompeted by other proteins
that interacted with the AREs or HuR binding sites overla-
pping with or located in close proximity to the CPEs. Future
studies employing direct binding assays should help answer this
question.
According to their primary structure, AREs are subdivided into
three different classes: class I AREs consist of several dispersed
copies of the AUUUA motif, class II AREs contain at least two
overlapping UUAUUUA(U/A)(U/A) nonamers, and class III
AREs are purely U-rich regions without an AUUUA motif
[22,34]. Initially, HuR had been described as interacting with all
three classes summarized in [34]. Since then several groups have
tried to identify a more specific HuR binding site [23,24]. The
binding pattern of HuR to Eph/ephrin 3’UTR probes used in our
study suggests binding of HuR to a single-stranded consensus
motif (NNUUNNUUU), which had been reported previously
[24].
HuR regulates expression of Eph/ephrins in cancer cell
lines
The human ELAV-like protein HuR is a well-characterized
ARE-binding protein that has been shown to stabilize a variety of
mRNA targets, including cyclooxygenase-2, cyclin A, cyclin B1,
and others [22]. However, HuR has also been shown to modulate
translation of a number of targets [35,36,37]. Finally, it was
demonstrated recently that mammalian Hu proteins regulate
polyadenylation by blocking poly(A) sites containing U-rich
sequences [38], and the Drosophila homolog of HuR, ELAV,
was shown to inhibit 3’-end processing within the non-neuronal
exon of the ewg pre-mRNA to promote neural splicing [39,40]. It
is widely accepted that HuR stabilizes transcripts by hindering
destabilizing factors from binding to the same or overlapping
sites. In the case of Eph/ephrins, where we see a destabilizing
effect of HuR, it would be interesting to investigate whether a
block of polyadenylation may contribute to destabilization of
Eph/ephrin mRNAs by HuR. Although speculative, this
hypothesis is supported by the fact that several of the HuR
binding sites found in Eph/ephrin 3’UTRs are located in
conserved clusters near the poly(A) site. Moreover, the blocking
effect observed by Zhu et al. (2007) was mediated by binding of
HuR to U-rich sequences located immediately upstream of the
cleavage site. It seems reasonable to assume that blocking
polyadenylation has consequences for the stability of the
respective transcripts because polyadenylation can enhance
RNA stability. In this context it is plausible that the position of
HuR binding sites in a given 3’UTR has a significant influence
on the functional outcome.
Whereas the destabilizing function HuR exerts on the EfnA2,
EphA2, and EphA4 transcripts was in accordance with an
increase in the RNA level for two of these messages after HuR
knock-down, EphA2 showed an unexpected decrease. This may
be due to secondary transcriptional effects, which could be
mediated by binding of HuR to the mRNAs encoding
transcription factors that regulate EphA2 expression. Good
candidates would be p53 or c-myc, which both (i) regulate
EphA2 transcription (p53 positively and c-myc negatively), and
(ii) are targets of HuR [17,41]. Moreover, we cannot exclude the
possibility that the potential use of alternative poly(A) sites that,
although as yet undetected, might be harboured in one or the
other Eph/ephrin 3’UTR could have contributed to the observed
differences in Eph/ephrin expression after HuR knockdown. The
use of recently developed HuR inhibitors [42] should help to
clarify this issue and make it possible to separate short-term
effects directly related to the stability of the target mRNA from
long-term secondary effects.
Overexpression of Eph/ephrins has been shown in several
tumor types and seems to be a prognostic marker that correlates
with tumor malignancy [11]. The highest levels of EphA2, for
example, are present on the most invasive tumor cells. It has been
suggested that not only overexpression of single Eph receptors
contribute to tissue invasiveness but also a disturbed receptor/
ligand density ratio. Also HuR was shown to have oncogenic
potential and its overexpression seems to correlate with advanced
stages of tumor malignancy [25]. As we show here HuR heavily
influences the expression of many Ephs and ephrins either by
For normalization a Renilla luciferase plasmid (pRL) was co-transfected. (C) 24 hours after transfection of a specific HuR RNAi oligonucleotide HeLa
cells were transfected with pGL3 promoter constructs as described in (B), and 48 hours later firefly luciferase activity was measured, and normalized
to the co-transfected pRL plasmid.
doi:10.1371/journal.pone.0002780.g007
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direct effects on the stability of the respective transcripts and/or by
secondary effects on the transcriptional levels. Therefore, it seems
plausible that overexpression of HuR in tumors completely
disarranges the expression patterns of multiple Ephs/ephrins
leading to a disequilibrium of receptor to ligand ratios and
consequently to enhanced invasiveness. In the future it will be
interesting to analyze a set of different tumor tissues for the
expression of both Eph/ephrins and HuR and correlate these data
with tumor phenotype and patient outcome.
Methods
Antibodies and siRNAs
Anti-KSRP antibody was a kind gift of Douglas Black.
Commercially available antibodies were used for detection of
HuR (Santa Cruz Biotech., 3A2), hnRNPA0, GAPDH (Santa
Cruz Biotech.) and AUF1 (Upstate Biotech.). For knockdown of
HuR validated siRNAs targeting two different regions of the
coding region were used (Qiagen, Hs_ELAVL1_1_HP and
Hs_ELAVL1_11_HP). As control a nonsilencing siRNA was used
(target sequence: AATTCTCCGAACGTGTCACGT).
Constructs
643–745, 646–841, 721–865, and 3101–3309 3’UTRs of
EfnA1, EfnA2, EphA2, and EphA4, respectively, were cloned in
the pGL3-Promoter vector (Promega) using the XbaI site located
downstream of the firefly luciferase sequence (position 1934).
Cell culture, RNA interference, Real Time RT-PCR and
Luciferase assays
Human cervical carcinoma HeLa cells were cultured in DMEM
(Lonza) supplemented with 10% fetal bovine serum, glutamine
and antibiotics. U373MG cells were cultured in EMEM,
supplemented with 10% fetal bovine serum, glutamine, nonessen-
tial amino acids, sodium pyruvate, and antibiotics. For siRNA
analyses, cells were seeded at a density of 16104 cells/well (24-well
plate) or at a density of 16105 (6-well plate) and transfected with
1 ml and 5 ml of 20 mM siRNA/well, respectively, using
OligofectamineTM in OptiMEM. After 72 h, cells were harvested
and the efficiency of the knock-down was tested by Western blot
with specific antibodies. For mRNA stability assays, cells were
treated with 5 mg/ml actinomycin D 48 h after transfection.
For Real Time RT-PCR, RNA was isolated using an RNeasy
Mini Kit (Qiagen). cDNA was synthesized using a TaqMan
reverse transcription reagents kit (Applied Biosystems), and real-
time PCR was carried out using a SYBRGreen PCR master mix
(Applied Biosystems) according to the manufacturer’s instructions
with an ABI 7900HT cycler under the following conditions: 50uC
for 2 min; 95uC for 10 min; 95uC for 15 s, 60uC for 1 min for 40
cycles; and 95uC for 15 min, 60uC for 15 min, 95uC for 15 min
for the dissociation stage. Primers used are listed (Table S3).
For Luciferase assays, cells were transfected either 24 h after
seeding in 24-well plates or 24 h after transfecting siRNAs with
475 ng of constructs cloned in pGL3-promoter vector and 95 pg
of pRL control vector using Lipofectamine2000 (Invitrogen).
Luciferase activity was measured 30 h or 48 h later using a Dual-
Luciferase Reporter Assay System (Promega).
In vitro transcription
32P-labeled cRNAs or biotin-labeled cRNAs corresponding to
the sense 643–734, 646–815, 447–528, 2935–3080, 1461–1727,
181–293, 721–841, 2497–2594, 3101–3271, 1129–1225, 401–521,
247–369, and 1201–1351 3’UTRs of EfnA1, EfnA2, EfnA4,
EfnB2, EfnB3, EphA1, EphA2, EphA3, EphA4, EphA5, EphA6,
EphA7, and EphB1, respectively, and to the corresponding
antisense 3’UTRs of EfnA1, EphA2, and EphA4 were produced
using purified PCR-amplified cDNA, which included the T7
Polymerase promoter sequence, and T7 polymerase (Promega)
according to the manufacturer’s procedure. Primer sequences are
given in Table S4. In-vitro-transcribed probes were DNAse-treated
and ethanol-precipitated.
UV-crosslinking assay
Brains from adult NMRI mice were frozen in liquid nitrogen,
pulverized using a mortar and pestle, resuspended in TKM buffer
(20 mM Tris [pH 7.5], 150 mM KCl, 5 mM MgCl2) supple-
mented with 1% NP40, 1 mM DTT, and complete protease
inhibitor cocktail (Roche), lysed with ultrasound, and centrifuged
at 12,0006g for 15 min at 4uC. Reaction mixtures containing
20 mg of protein lysate in reaction buffer (5.2 mM HEPES
[pH 7.9], 50 mM KCl, 10 mM DTT, 5 mg/ml heparin, 1%
glycerol, 40 mg/ml yeast tRNA) and 250,000 cpm of radiolabeled
probe were incubated for 10 min at room temperature, UV-
crosslinked for 10 min in a UV Stratalinker 1800 (Stratagene) and
digested with 1 U each of RNAse A and RNAse T1 for 15 min at
37uC. Complexes were resolved by electrophoresis through SDS–
10% acrylamide gels, after denaturation at 95uC for 5 min. Gels
were dried and exposed to X-ray film.
RNA–protein pulldown
To obtain pure protein lysate, mouse brains were treated as
described above. After the first centrifugation at 12,0006g,
ultracentrifugation was performed at 100,0006g for 1 h at 4uC.
Reaction mixtures containing 6 mg (for Coomassie staining) or
200 mg (for Western blot analysis) of protein lysate in TKM buffer
supplemented with 1% NP40, 1 mM DTT, complete protease
inhibitor cocktail (Roche), 100 U of RNasin (Promega), and 40 mg
(for Coomassie staining) or 3 mg (for Western blot analysis) of
biotin-labeled probe were incubated for 1 h at 4uC, followed by
the addition of streptavidin magnetic beads and incubation for 2 h
at 4uC. After washing and denaturation at 95uC for 5 min,
proteins were resolved by electrophoresis through SDS-10%
acrylamide gels. Gels were either stained with colloidal Coomassie
and analyzed by mass spectrometry or blotted on PVDF
membranes and Western blot analyses performed with antibodies
directed against the respective proteins.
Mass spectrometry
The peptide mixture was identified by chromatographic
separation on an LC Packings 75 _m PepMap C18 column
(Dionex, Idstein, Germany) using a capillary liquid chromatogra-
phy (CapLC) system delivering a gradient to formic acid (0.1%)
and acetonitrile (80%). Eluted peptides were ionized by electro-
spray ionization on a Q-TOF hybrid mass spectrometer (Micro-
mass, Manchester, UK). The mass spectral data were processed
into peak lists containing the m/z value, charge state of the parent
ion, fragment ion masses and intensities, and correlated with the
SwissProt database using Mascot software [43].
Immunoprecipitation and RT-PCR
For immunoprecipitation of endogenous mRNPs the protocol
published by [44] was used with the following modifications: For
immunoprecipitation of HuR the protein lysates were precleared
for 1 h at 4uC with protein-G Agarose. Complexes were
immunoprecipitated for 2 h at room temperature using 10 mg of
HuR antibody or the corresponding amount of IgG, followed by
incubation for 1 h at room temperature in the presence of protein-
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G agarose. RNA was extracted using an RNeasy Mini Kit
(Qiagen).
For RT-PCR, 50% of the RNA isolated from the immunopre-
cipitates (IPs) was reverse-transcribed using random hexamers,
and SSIII reverse transcriptase (RT) (Invitrogen). The other 50%
served as negative controls (no RT in the reaction mixture). 1–3 ml
of the resulting cDNA was used for PCR amplification using 95uC
(5 min) followed by 30–35 cycles 95uC (30 s), 55uC (1 min), and
72uC (1 min), then 5 min at 72uC (primer sequences are given in
Table S3).
Bioinformatics analyses
To obtain the complete sequences of the 3’UTRs we first
extracted all available sequences from the GenBank database of
the NCBI. Transcripts were considered complete if they were
polyadenylated at their 3’ends. Incomplete transcripts were
extended to the poly(A) tail by aligning 3’-complete EST data
using the software program CAP3 (http://pbil.univ-lyon1.fr/cap3.
php) [45].
Eph and ephrin 3’UTRs were scanned for known binding
motifs for RNA-binding proteins using BioPerl [30]. For detection
of G quartets, CPEs and AREs we used the minimal elements
WGG WGG WGG WGG, TTTTAT, and ATTTA which have
been shown to suffice for binding of interacting proteins [10] [26].
For detection of HuR binding sites, Eph and ephrin 3’UTRs were
scanned for the sequence motif NNUUNNUUU [24] using
TransTerm (http://uther.otago.ac.nz/Transterm.html) [46].
RNA secondary structures were predicted using Mfold [47].
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